SmartSummary Rx gives an enhanced level of control to each member by helping them track how much they've spent to date on prescription drugs. This is a valuable benefit because of Medicare's built-in coverage gap, also commonly known as the "doughnut hole." After a member's drug costs reach $2,250, a Medicare consumer in most cases will have to cover $2,850 in out-of-pocket costs before coverage resumes. The tracking feature, found only in SmartSummary Rx, allows beneficiaries to anticipate and better plan for future medication expenses.
"SmartSummary Rx is a revolutionary advancement unlike anything in the health benefits industry today," said Jonathan T. Lord, M.D., senior vice president and chief innovation officer of Humana. "We are constantly looking for ways to help consumers understand their health benefits and make better use of the health system. During an 18-month consumer research project, we discovered that traditional claims receipts - known as Explanations of Benefits, or EoBs - lack the clarity and personal relevance consumers need to feel confident in managing their health. We developed SmartSummary Rx to give members what they need to take more control of their personal health care experience."
Offering a significantly more comprehensive view of their prescription claims and health spending than the traditional EoB, which details only one claim at a time, the patent-pending SmartSummary Rx was developed with financial planning in mind. SmartSummary Rx consolidates health care cost details and plan information, while providing personalized messaging in one easily accessible and user-friendly document that aggregates information about medical events and their costs throughout the plan year.
SmartSummary Rx also includes a portable prescription record, which provides beneficiaries with all the details needed to accurately track their prescriptions, including dosage, previous refill dates, prescribing doctor and pharmacy information.
SmartSummary Rx provides tools for consumers to communicate effectively with their doctors and pharmacists about medications to help avoid potential harmful drug interactions. Because it is tailored to each individual, SmartSummary Rx even offers information about potential lower-cost medications that are covered by their plan, so the member and their clinician can together make educated choices about their care options.
"The primary principle guiding development of SmartSummary Rx was to provide breakthrough guidance to members in a way that is easy to understand, easy to use and immediately actionable," Dr. Lord said. "Through consumer research we discovered that people want help navigating the highly fragmented health care system that often includes confusing cost and care options. SmartSummary Rx was developed to give consumers a level of confidence and control they have never before experienced."
SmartSummary Rx statements will roll out monthly to Medicare beneficiaries starting in February 2006. Commercial SmartSummary statements have been developed for Humana's non-Medicare members and additional variations are in development for those with dental and financial accounts. SmartSummary Rx statements will be sent to each member as a paper-based document. For those who prefer electronic versions, all summaries can be accessed online through the member's personalized MyHumana.com site.
Humana Inc., headquartered in Louisville, Ky., is one of the nation's largest publicly traded health benefits companies, with more than 7 million medical members. Humana offers a diversified portfolio of health insurance products and related services - through traditional and consumer-choice plans - to employer groups, government-sponsored plans, and individuals.
Over its 45-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio.
More information regarding Humana is available to investors via the Investor Relations page of the company's Web site at http://www.humana.com, including copies of:
-- Annual report to stockholders
-- Securities and Exchange Commission filings;
-- Most recent investor conference presentation
-- Quarterly earnings news releases
-- Replay of most recent earnings release conference call
-- Calendar of events (includes upcoming earnings conference call dates, times, and access number, as well as planned interaction with institutional investors)
-- Corporate Governance Information